Intuitive Surgical (NASDAQ:ISRG) SVP Sells $312,831.45 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark Brosius sold 645 shares of Intuitive Surgical stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $485.01, for a total transaction of $312,831.45. Following the transaction, the senior vice president directly owned 1,613 shares of the company’s stock, valued at $782,321.13. This represents a 28.57% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Mark Brosius also recently made the following trade(s):

• On Thursday, March 5th, Mark Brosius sold 648 shares of Intuitive Surgical stock. The stock was sold at an average price of $495.20, for a total value of $320,889.60.
• On Wednesday, March 4th, Mark Brosius sold 2,362 shares of Intuitive Surgical stock. The shares were sold at an average price of $498.68, for a total value of $1,177,882.16.
• On Tuesday, March 3rd, Mark Brosius sold 648 shares of Intuitive Surgical stock. The stock was sold at an average price of $488.10, for a total value of $316,288.80.
• On Monday, December 15th, Mark Brosius sold 464 shares of Intuitive Surgical stock. The shares were sold at an average price of $548.49, for a total value of $254,499.36.
• On Friday, December 12th, Mark Brosius sold 4,500 shares of Intuitive Surgical stock. The stock was sold at an average price of $547.36, for a total transaction of $2,463,120.00.

Intuitive Surgical Stock Performance

ISRG traded down $7.71 during midday trading on Tuesday, hitting $485.85. The company had a trading volume of 1,545,337 shares, compared to its average volume of 2,028,645. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $603.88. The company has a market capitalization of $172.54 billion, a PE ratio of 61.58, a P/E/G ratio of 3.78 and a beta of 1.66. The firm’s 50-day simple moving average is $520.00 and its 200-day simple moving average is $512.68.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating the consensus estimate of $2.27 by $0.26. The business had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. Intuitive Surgical’s revenue was up 18.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.21 earnings per share. As a group, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of recent research reports. Piper Sandler restated an “overweight” rating and set a $620.00 target price (up from $610.00) on shares of Intuitive Surgical in a research report on Friday, January 23rd. Wells Fargo & Company upped their target price on shares of Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a research report on Friday, December 12th. Truist Financial boosted their price target on shares of Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a research note on Thursday, December 18th. Raymond James Financial raised their price objective on shares of Intuitive Surgical from $603.00 to $615.00 and gave the company an “outperform” rating in a research note on Friday, January 23rd. Finally, The Goldman Sachs Group reiterated a “buy” rating and set a $714.00 target price on shares of Intuitive Surgical in a research report on Friday, January 9th. Two analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $615.86.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. PeakShares LLC acquired a new position in Intuitive Surgical during the fourth quarter valued at approximately $1,040,000. Corient Private Wealth LLC raised its holdings in Intuitive Surgical by 17.7% in the fourth quarter. Corient Private Wealth LLC now owns 378,838 shares of the medical equipment provider’s stock worth $214,891,000 after purchasing an additional 57,055 shares during the period. Union Savings Bank bought a new position in shares of Intuitive Surgical during the fourth quarter worth $67,000. Storen Legacy Partners LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $217,000. Finally, Worthington Financial Partners LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at $366,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.